SkinHealth Q2 net loss narrows to $2.7 million; net sales fall 7.8% to $72.1 million YoY
SKIN•Rebrand and outlook
- SkinHealth Systems reaffirmed its rebrand as a shift toward a scalable skin health ecosystem, with CEO Pedro Malha calling it a “fundamental evolution” in how it competes.
- Guidance was revised to Q3 2026 net sales of $65 million-$70 million and FY 2026 net sales of $280 million-$290 million.
Q2 results and segment performance
- SkinHealth Systems posted Q2 2026 net sales of $72.1 million, down 7.8% year over year.
- Net loss was $2.7 million, swinging from net income a year earlier; adjusted EBITDA rose to $17 million.
- Delivery systems net sales fell 18.4% to $18.3 million, while consumables net sales slipped 3.5% to $53.9 million.
